Nonbenzodiazepine: Difference between revisions

Line 29: Line 29:
'''β-Carbolines'''
'''β-Carbolines'''
* [[Abecarnil]]
* [[Abecarnil]]
* [[Azocarnil (photoswitchable)]]<ref>{{cite journal | vauthors = Maleeva G, Nin-Hill A, Wirth U, Rustler K, Ranucci M, Opar E, Rovira C, Bregestovski P, Zeilhofer HU, König B, Alfonso-Prieto M, Gorostiza P | title = Light-Activated Agonist-Potentiator of GABA<sub>A</sub> Receptors for Reversible Neuroinhibition in Wildtype Mice | journal = Journal of the American Chemical Society | date = October 2024 | volume = 146 | issue = 42 | pages = 28822–28831 | pmid = 39383450 | doi = 10.1021/jacs.4c08446 | pmc = 11503767 | bibcode = 2024JAChS.14628822M }}</ref>
* [[Azocarnil]]
* [[Gedocarnil]]
* [[Gedocarnil]]
* [[SL-651,498]]
* [[ZK-93423]]


[[Category:Pharmacology]]
[[Category:Pharmacology]]

Revision as of 21:48, 20 May 2026

Background

Core structures of selected nonbenzodiazepines (left three diagrams) and the structure of benzodiazepines (right) for comparison.
  • Nonbenzodiazepines (i.e., "Z-drugs"), are a class of psychoactive, depressant, sedative, hypnotic, anxiolytic drugs that are benzodiazepine-like in uses, such as for treating insomnia and anxiety.
  • Nonbenzodiazepine pharmacodynamics are similar in mechanism of action to benzodiazepine drugs, acting as GABAA receptor positive allosteric modulators of the benzodiazepine site, and therefore exhibit similar benefits, side effects, and risks.
    • However, nonbenzodiazepines have dissimilar or entirely different chemical structures, so are unrelated to benzodiazepines on a molecular level.

Classes

Imidazopyridines

Pyrazolopyrimidines

Cyclopyrrolones

β-Carbolines